This was a large, well-run trial in people who had already had several skin cancers. Taking nicotinamide by mouth for a year lowered the rate of new non-melanoma skin cancers and precancerous spots (actinic keratoses). Note: this is about the oral supplement, not topical skincare, and applies to high-risk patients, not the general public.